This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stock Futures Fall Amid China Banking Concerns, Caterpillar Weakness

NEW YORK (TheStreet) -- Stock futures were pointing to a pullback from new highs and a five-session advance as China, the world's second-largest economy, showed signs of economic instability and Caterpillar (CAT - Get Report), the construction and mining equipment leader, reported a quarterly profit that fell short of expectations.

Futures for the S&P 500 were slumping 8.75 points, or 8.27 points below fair value, to 1,740.75. Futures for the Dow Jones Industrial Average were sinking by 61 points, or 64.66 points below fair value, to 15,337. Futures for the Nasdaq were down 17.5 points, or 19.83 points below fair value, to 3,339.

China concerns weighed on international markets and U.S. stock futures as the country revealed a tripling of write-offs in bad bank loans and as short-term money rates in China spiked amid signs that the central bank could tighten liquidity in order to temper inflation.

Nearly 40 S&P 500 components were expected to report their earnings on Wednesday.

Caterpillar was sinking by 4.62% to $85.05 after the Peoria-based company's net income for the third-quarter missed analyst forecasts by 21 cents at $1.45 a share and slashed its full-year sales outlook. CEO Doug Oberhelman said that it has been a "difficult" year for Caterpillar, particularly in mining.

Must Read: What Jobs Report? Stocks Gain on Stimulus Support

Boeing(BA - Get Report) was jumping nearly 3% to $126.14 after the aerospace giant beat Wall Street earnings estimates, raised guidance and projected continuing growth in production of the 787 Dreamliner. Boeing said third-quarter earnings rose 16% on the strength of higher commercial aircraft deliveries.

Bristol-Myers Squibb (BMY - Get Report) was slipping 1.23% to $49.12 even after the pharmaceutical company reported stronger-than-anticipated earnings driven by cancer and diabetes treatments, as it reiterated the company's previous 2013 earnings estimate of $1.70 to $1.78 a share.

Northrop Grumman (NOC - Get Report) was rising 1.03% to $102.50 after the defense contractor boosted the company's full-year outlook as third-quarter earnings of $1.97 a share exceeded the Wall Street consensus by 15 cents and revenue beat expectations.

A number of economic releases were released before the market open. September import prices, excluding the oil component, ticked up 0.1% after being down 0.2% the previous month, according to the Bureau of Labor Statistics.

The Mortgage Bankers' Association's seasonally adjusted weekly purchase applications index showed a small rise of 1% in the week of Oct. 18 after slipping 5% in the preceding week.

The FTSE in London was down 0.48% and the DAX in Germany was off 0.42%. The Nikkei 225 in Japan finished behind by 1.95% and the Hong Kong Hang Seng closed off by 1.36%.

December crude oil contracts were down $1.12 to $97.18 a barrel and December gold futures were falling $10.60 to $1,332 an ounce.

The benchmark 10-year Treasury was rising 4/32, diluting the yield to 2.499%. The dollar was up 0.1% to $79.31 according to the U.S. dollar index. Markets broke fresh highs on Tuesday after a weak jobs report fueled speculation the Federal Reserve will maintain the monetary stimulus measures that have helped boost equities to their biggest gains in 16 years.

-- Written by Andrea Tse in New York

>To contact the writer of this article, click here: Andrea Tse.>  

Copyright 2013 Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. AP contributed to this report.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BMY $72.26 2.89%
BA $134.80 -1.66%
CAT $77.69 -1.30%
NOC $205.61 -0.67%
AAPL $95.03 -2.90%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs